| 1 | [SID26725322] | Active | Potency | 7.9433 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 2 | [SID26725322] | Active | Potency | 10 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 3 | [SID26725322] | Active | Potency | 10 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 4 | [SID26725322] | Active | Potency | 12.5893 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 5 | [SID26725322] | Active | Potency | 12.5893 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 6 | [SID26725322] | Active | Potency | 12.5893 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 7 | [SID26725322] | Active | Potency | 12.5893 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 8 | [SID26725322] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 9 | [SID26725322] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 10 | [SID26725322] | Active | Potency | 15.8489 | qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase [AID602233, Type: confirmatory] | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase | | AID | 602233 | | BioAssay type | confirmatory | | Target | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] | | PubMed | | | Data Table |  |
|
| 11 | [SID26725322] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 12 | [SID26725322] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 13 | [SID26725322] | Active | Potency | 25.1189 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 14 | [SID26725322] | Active | Potency | 25.1189 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 15 | [SID26725322] | Active | Potency | 31.6228 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 16 | [SID26725322] | Active | EC50 | 33.149 | Fluorescent Polarization Homogeneous Dose Response HTS to Indentify Inhibitors of Mex-5 Binding to TCR-2 [AID1960, Type: confirmatory] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | EC50 | 33.149 [uM] | | BioAssay | Fluorescent Polarization Homogeneous Dose Response HTS to Indentify Inhibitors of Mex-5 Binding to TCR-2 | | AID | 1960 | | BioAssay type | confirmatory | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 17 | [SID26725322] | Active | EC50 | 33.149 | Fluorescent Polarization Homogeneous Dose Response HTS to Indentify Inhibitors of Mex-5 Binding to TCR-2 [AID1960, Type: confirmatory] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | EC50 | 33.149 [uM] | | BioAssay | Fluorescent Polarization Homogeneous Dose Response HTS to Indentify Inhibitors of Mex-5 Binding to TCR-2 | | AID | 1960 | | BioAssay type | confirmatory | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 18 | [SID26725322] | Active | Potency | 35.4813 | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). [AID588795, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). | | AID | 588795 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 19 | [SID26725322] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 20 | [SID26725322] | Active | Potency | 56.2341 | Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) - Round 2 Cherry Picks [AID504841, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) - Round 2 Cherry Picks | | AID | 504841 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 21 | [SID26725322] | Active | EC50 | 91.471 | Fluorescent Polarization Homogeneous Dose Response HTS to Indentify Inhibitors of POS-1 Binding to mex-3-RNA [AID1964, Type: confirmatory] | POsterior Segregation family member (pos-1) [Caenorhabditis elegans] [gi:17562800] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | EC50 | 91.471 [uM] | | BioAssay | Fluorescent Polarization Homogeneous Dose Response HTS to Indentify Inhibitors of POS-1 Binding to mex-3-RNA | | AID | 1964 | | BioAssay type | confirmatory | | Target | POsterior Segregation family member (pos-1) [Caenorhabditis elegans] [gi:17562800] | | PubMed | | | Data Table |  |
|
| 22 | [SID26725322] | Active | | | uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493011, Type: screening] | APOBEC3A gene product [Homo sapiens] [gi:21955158] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493011 | | BioAssay type | screening | | Target | APOBEC3A gene product [Homo sapiens] [gi:21955158] | | PubMed | | | Data Table |  |
|
| 23 | [SID26725322] | Active | | | uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) [AID493160, Type: screening] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) | | AID | 493160 | | BioAssay type | screening | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 24 | [SID26725322] | Active | | | uHTS fluorescent assay for identification of inhibitors of ATG4B [AID504462, Type: screening] | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | uHTS fluorescent assay for identification of inhibitors of ATG4B | | AID | 504462 | | BioAssay type | screening | | Target | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] | | PubMed | | | Data Table |  |
|
| 25 | [SID26725322] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 26 | [SID26725322] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 27 | [SID26725322] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 28 | [SID26725322] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 29 | [SID26725322] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 30 | [SID26725322] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 31 | [SID26725322] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 32 | [SID26725322] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 33 | [SID26725322] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 34 | [SID26725322] | Active | | | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay [AID588402, Type: other] | phospholipase A2 precursor [Homo sapiens] [gi:4505847] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay | | AID | 588402 | | BioAssay type | other | | Target | phospholipase A2 precursor [Homo sapiens] [gi:4505847] | | PubMed | | | Data Table |  |
|
| 35 | [SID26725322] | Active | | | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay [AID588402, Type: other] | phospholipase A2 precursor [Homo sapiens] [gi:4505847] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay | | AID | 588402 | | BioAssay type | other | | Target | phospholipase A2 precursor [Homo sapiens] [gi:4505847] | | PubMed | | | Data Table |  |
|
| 36 | [SID26725322] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 37 | [SID26725322] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 38 | [SID26725322] | Active | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae specifically LAP4 Second Cherry Pick Compounds [AID2621, Type: screening] | LAP4 [Saccharomyces cerevisiae] [gi:486173] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae specifically LAP4 Second Cherry Pick Compounds | | AID | 2621 | | BioAssay type | screening | | Target | LAP4 [Saccharomyces cerevisiae] [gi:486173] | | PubMed | | | Data Table |  |
|
| 39 | [SID26725322] | Active | | | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC [AID463187, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC | | AID | 463187 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID26725322] | Active | | | 384-well Z-Lyte format Hck-Nef inhibitor HTS: Confirmation Assays [AID463188, Type: other] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | 384-well Z-Lyte format Hck-Nef inhibitor HTS: Confirmation Assays | | AID | 463188 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID26725322] | Active | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID26725322] | Active | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN. [AID2025, Type: screening] | RPL19A [Saccharomyces cerevisiae] [gi:536029] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN. | | AID | 2025 | | BioAssay type | screening | | Target | RPL19A [Saccharomyces cerevisiae] [gi:536029] | | PubMed | | | Data Table |  |
|
| 43 | [SID26725322] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 44 | [SID26725322] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 45 | [SID26725322] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 46 | [SID26725322] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 47 | [SID26725322] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 48 | [SID26725322] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 49 | [SID26725322] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 50 | [SID26725322] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26725322 | | CID | 16745545 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|